
The Lowly Dawn Simulator
Is it time to think outside the light box for treatment of seasonal depression?
[[{"type":"media","view_mode":"media_crop","fid":"54691","attributes":{"alt":"","class":"media-image","id":"media_crop_2016760301975","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"6849","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]
RESEARCH UPDATE
“Light therapy” makes everyone think of
Enter the lowly dawn simulator. You’ve probably heard of it, and a few readers are actually using one every day this winter. It gradually raises the intensity of a simple bedside light (not a light box) over 30 to 60 minutes in the morning, “simulating dawn.” These devices have produced better outcomes than plausible placebo devices in seasonal depression1 and nearly as good outcomes as light box therapy,2 indeed better than a light box in one randomized comparison
A dawn simulator is much easier to use regularly than a light box. The gradually increasing light reaches the retina through your translucent eyelids. By the time you wake up, the treatment is complete. Just get up and start your day. No 30-minute halt to sit in front of a bright light.
To paraphrase a
On the other hand, remember that conventional antidepressants have very little direct evidence for efficacy in bipolar depression either, at least in bipolar I.5 As the British Association for Psychopharmacology summarized in their 2016
Why underutilized?
Why not then just start with a dawn simulator for your next patient with bipolar depression? Answer: unlike pills (but like light boxes), dawn simulators require a lot of explaining. First, one must help a patient understand that turning on a standard bedside light gradually can have an antidepressant effect, while the very same light, turned on suddenly, would not. (The latter does not entrain circadian rhythm as well.7)
My
Second, one must explain how to use the device, which for many of them is not simple. Even my favorite-because of its
To help patients around this barrier, our office purchased a couple of the $20 simulators and we sell them at our cost to patients at our front desk (using the money to buy more as we run low). If that’s impractical for you, at least buy one and keep it in your office as an example. (Maybe two: set the other one up in your bedroom to try out! It probably won’t make it to your office after that.)
Here’s a twist, however. I’ve always thought that once patients set up a dawn simulator properly, they would prefer it to light box therapy. Interestingly, a recent
Are there
any
risks? One reporter for NBC News described being pounced upon by her Pomeranian one morning while trying a dawn simulator.
Actually, both treatments were equally effective, leading to 42% and 44% reductions in depression scale scores for dawn simulators and light boxes, respectively. But the preference factor illustrates that understanding patients’ expectations for light therapy is important: if they think a dawn simulator is a poor substitute for the “real thing” (a bright light box), that could affect the outcome of their light therapy.
Which one?
The few quality randomized trials of dawn simulators have not established a particular design to recommend (thus, my choice based on cost). Recently developed smartphone apps for Android and Apple have not been tested clinically. Their instant availability, portability, and price (most are free) are attractive. Caution: some use the phone face, some the flash. A research trial to establish efficacy of each is needed. Patients who do not respond to a trial of a phone app should not conclude that a dawn simulator using a bedside lamp would not be effective.
Are there any risks? One reporter for NBC News described being
Disclosures:
Dr. Phelps is Director of the Mood Disorders Program at Samaritan Mental Health in Corvallis, Ore. He is the Bipolar Disorder Section Editor for Psychiatric Times. Dr. Phelps stopped accepting honoraria from pharmaceutical companies in 2008 but receives honoraria from McGraw-Hill and W.W. Norton & Co. for his books on bipolar disorders.
References:
1. Golden RN, Gaynes BN, Ekstrom RD, et al.
2. Terman M, Terman JS.
3. Avery DH, Eder DN, Bolte MA, et al.
4. Zimmerman M, Posternak MA, Attiullah N, et al.
5. Pacchiarotti I, Bond DJ, Baldessarini RJ, et al.
6. Goodwin GM, Haddad PM, Ferrier IN, et al.
7. Norden MJ, Avery DH.
8. Danilenko KV, Ivanova IA.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.